Articles with the topic: phosphodiesterase

Pfizer Amaryllis trial ends in disappointment: no improvement in Huntington's disease symptoms

Pfizer Amaryllis trial ends in disappointment: no improvement in Huntington's disease symptoms

Pfizer announces the 'Amaryllis' trial of a PDE-10 inhibitor drug failed to improve symptoms of HD

Professor Ed Wild | December 16, 2016

'Buzzilia' from the Huntington's Disease World Congress: day 1

'Buzzilia' from the Huntington's Disease World Congress: day 1

Buzzilia, day 1: Jeff and Ed's roundup of happenings from the opening day of the HD World Congress in Rio de Janeiro

Professor Ed Wild | September 15, 2013

Video: What’s new in Huntington's disease research 2012

Video: What’s new in Huntington's disease research 2012

Watch Ed Wild's address to the European Huntington's Association on how HD research works and the most promising poss

Professor Ed Wild | October 10, 2012

Phosphodiesterase inhibitors: new HD drugs entering trials soon

Phosphodiesterase inhibitors: new HD drugs entering trials soon

CHDI and Pfizer announce exciting animal work and plans for a human trial with a drug targeting 'phosphodiesterases'.

Carly Desmond | June 07, 2012

Start here

New to HD research? Click here to get an overview

Follow HDBuzz

Sign up to our monthly email summary by entering your email address below or get more options on our mailing list page

Suggest an article

Is there something you want us to write about? Tell us about it here. We consider all suggestions but can't promise to write content about any particular suggestion.

Email editors@hdbuzz.net

Donate

Please consider making a donation if you value the services that HDBuzz provides. We want HDBuzz to be sustainable so that we can continue to report unbiased science to the HD community.

With your support, we can ensure the continuity of our services. Nothing is expected, but everything is appreciated and sustains what we do at HDBuzz. Please consider giving what you're able. More information...

Donate